HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system.

Helena FrayleSilvia GoriMartina RizziBianca Nives GrazianiElisa VianPaolo Giorgi RossiAnnarosa Del Mistro

Published in: BMC women's health (2019)

The new cobas 6800/8800 HPV assay run on the 6800 instrument is suitable for use in large centralized laboratories included within population-based cervical cancer screening programs.

Keyphrases

cervical cancer screening
high throughput
public health
patient reported outcomes
single cell